Annual CFF
$22.70 M
+$3.25 M+16.71%
31 December 2023
Summary:
VBI Vaccines annual cash flow from financing activities is currently $22.70 million, with the most recent change of +$3.25 million (+16.71%) on 31 December 2023. During the last 3 years, it has fallen by -$99.69 million (-81.45%).VBIV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$843.00 K
+$571.00 K+209.93%
31 March 2024
Summary:
VBI Vaccines quarterly cash flow from financing activities is currently $843.00 thousand, with the most recent change of +$571.00 thousand (+209.93%) on 31 March 2024. Over the past year, it has dropped by -$21.58 million (-96.24%).VBIV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$23.54 M
+$843.00 K+3.71%
31 March 2024
Summary:
VBI Vaccines TTM cash flow from financing activities is currently $23.54 million, with the most recent change of +$843.00 thousand (+3.71%) on 31 March 2024. Over the past year, it has increased by +$1.11 million (+4.97%).VBIV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.7% | -96.2% | +5.0% |
| 3 y3 years | -81.5% | -88.0% | -58.6% |
| 5 y5 years | -48.0% | -97.8% | -71.0% |
VBIV Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -81.5% | -98.7% | -83.7% |
VBI Vaccines Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $843.00 K(+209.9%) | $23.54 M(+3.7%) |
| Dec 2023 | $22.70 M(+16.7%) | $272.00 K(-98.8%) | $22.70 M(+1.2%) |
| Sept 2023 | - | $22.43 M(>+9900.0%) | $22.43 M(+15.4%) |
| June 2023 | - | $0.00(0.0%) | $19.44 M(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $19.44 M(-0.1%) |
| Dec 2022 | $19.45 M(-56.1%) | $0.00(-100.0%) | $19.45 M(-12.9%) |
| Sept 2022 | - | $19.44 M(>+9900.0%) | $22.34 M(+124.3%) |
| June 2022 | - | $0.00(-100.0%) | $9.96 M(-56.1%) |
| Mar 2022 | - | $12.00 K(-99.6%) | $22.68 M(-48.8%) |
| Dec 2021 | $44.29 M(-63.8%) | $2.89 M(-59.0%) | $44.29 M(-22.2%) |
| Sept 2021 | - | $7.05 M(-44.5%) | $56.93 M(-42.6%) |
| June 2021 | - | $12.72 M(-41.2%) | $99.17 M(-31.4%) |
| Mar 2021 | - | $21.62 M(+39.3%) | $144.62 M(+18.2%) |
| Dec 2020 | $122.39 M(+227.1%) | $15.53 M(-68.5%) | $122.39 M(+14.6%) |
| Sept 2020 | - | $49.29 M(-15.3%) | $106.79 M(+12.4%) |
| June 2020 | - | $58.17 M(-9795.5%) | $94.99 M(+158.0%) |
| Mar 2020 | - | -$600.00 K(+659.5%) | $36.81 M(-1.6%) |
| Dec 2019 | $37.41 M(-14.2%) | -$79.00 K(-100.2%) | $37.41 M(-53.8%) |
| Sept 2019 | - | $37.49 M(>+9900.0%) | $81.05 M(+86.1%) |
| June 2019 | - | $0.00(0.0%) | $43.55 M(-0.1%) |
| Mar 2019 | - | $0.00(-100.0%) | $43.61 M(-0.0%) |
| Dec 2018 | $43.62 M(-35.1%) | $43.55 M(>+9900.0%) | $43.62 M(-35.2%) |
| Sept 2018 | - | $0.00(-100.0%) | $67.29 M(0.0%) |
| June 2018 | - | $60.00 K(+1100.0%) | $67.29 M(+0.1%) |
| Mar 2018 | - | $5000.00(-100.0%) | $67.23 M(-0.0%) |
| Dec 2017 | $67.24 M(+84.3%) | $67.22 M(>+9900.0%) | $67.24 M(+189.0%) |
| Sept 2017 | - | $0.00(0.0%) | $23.26 M(+1.0%) |
| June 2017 | - | $0.00(-100.0%) | $23.04 M(-36.9%) |
| Mar 2017 | - | $16.00 K(-99.9%) | $36.50 M(+0.0%) |
| Dec 2016 | $36.48 M(+6533.3%) | $23.25 M(<-9900.0%) | $36.48 M(+175.7%) |
| Sept 2016 | - | -$225.00 K(-101.7%) | $13.23 M(-1.7%) |
| June 2016 | - | $13.46 M(>+9900.0%) | $13.46 M(>+9900.0%) |
| Mar 2016 | - | $0.00(-100.0%) | $32.60 K(-99.4%) |
| Dec 2015 | $550.00 K(-90.1%) | - | - |
| June 2015 | - | $32.60 K(-106.4%) | $5.55 M(-0.3%) |
| Mar 2015 | - | -$512.60 K(-108.5%) | $5.56 M(-8.4%) |
| Mar 2015 | $5.56 M(>+9900.0%) | - | - |
| Dec 2014 | - | $6.03 M(<-9900.0%) | $6.08 M(>+9900.0%) |
| Sept 2014 | - | -$2100.00(-104.5%) | $44.80 K(-4.5%) |
| June 2014 | - | $46.90 K(>+9900.0%) | $46.90 K(>+9900.0%) |
| Mar 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2013 | - | $0.00(0.0%) | $6500.00(+4.8%) |
| Sept 2013 | - | $0.00(0.0%) | $6200.00(-82.0%) |
| June 2013 | - | $0.00(-100.0%) | $34.40 K(0.0%) |
| Mar 2013 | $34.40 K(-99.9%) | $6500.00(-2266.7%) | $34.40 K(-98.2%) |
| Dec 2012 | - | -$300.00(-101.1%) | $1.93 M(-32.0%) |
| Sept 2012 | - | $28.20 K(>+9900.0%) | $2.84 M(+8957.8%) |
| June 2012 | - | $0.00(-100.0%) | $31.30 K(-99.9%) |
| Mar 2012 | $52.77 M | $1.90 M(+109.4%) | $52.77 M(+0.2%) |
| Dec 2011 | - | $907.30 K(-132.7%) | $52.69 M(-2.4%) |
| Sept 2011 | - | -$2.78 M(-105.3%) | $53.97 M(-19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | $52.74 M(+2797.3%) | $67.34 M(+356.8%) |
| Mar 2011 | $14.74 M(+283.9%) | $1.82 M(-16.9%) | $14.74 M(+10.2%) |
| Dec 2010 | - | $2.19 M(-79.3%) | $13.38 M(-3.5%) |
| Sept 2010 | - | $10.60 M(+7785.2%) | $13.87 M(+248.9%) |
| June 2010 | - | $134.40 K(-70.6%) | $3.97 M(+3.5%) |
| Mar 2010 | $3.84 M(+1074.0%) | $457.40 K(-82.9%) | $3.84 M(+7.4%) |
| Dec 2009 | - | $2.68 M(+280.6%) | $3.57 M(+308.5%) |
| Sept 2009 | - | $703.80 K(>+9900.0%) | $875.00 K(+430.3%) |
| June 2009 | - | $0.00(-100.0%) | $165.00 K(-49.6%) |
| Mar 2009 | $327.10 K(-19.4%) | $191.50 K(-1043.3%) | $327.10 K(+173.5%) |
| Dec 2008 | - | -$20.30 K(+227.4%) | $119.60 K(-47.2%) |
| Sept 2008 | - | -$6200.00(-103.8%) | $226.60 K(-15.8%) |
| June 2008 | - | $162.10 K(-1113.1%) | $269.00 K(-33.7%) |
| Mar 2008 | $405.60 K(-29.4%) | -$16.00 K(-118.5%) | $405.60 K(-42.6%) |
| Dec 2007 | - | $86.70 K(+139.5%) | $706.80 K(-10.9%) |
| Sept 2007 | - | $36.20 K(-87.9%) | $793.40 K(+4.6%) |
| June 2007 | - | $298.70 K(+4.7%) | $758.50 K(+32.0%) |
| Mar 2007 | $574.70 K(-30.1%) | $285.20 K(+64.6%) | $574.60 K(-40.3%) |
| Dec 2006 | - | $173.30 K(>+9900.0%) | $962.60 K(+2.6%) |
| Sept 2006 | - | $1300.00(-98.9%) | $937.80 K(+0.1%) |
| June 2006 | - | $114.80 K(-82.9%) | $936.50 K(+14.0%) |
| Mar 2006 | $821.70 K(+100.9%) | $673.20 K(+353.3%) | $821.70 K(+866.7%) |
| Dec 2005 | - | $148.50 K(>+9900.0%) | $85.00 K(+2831.0%) |
| Sept 2005 | - | $0.00(0.0%) | $2900.00(-96.9%) |
| June 2005 | - | $0.00(-100.0%) | $94.50 K(-76.9%) |
| Mar 2005 | $409.10 K(-11.0%) | -$63.50 K(-195.6%) | $409.10 K(-42.3%) |
| Dec 2004 | - | $66.40 K(-27.5%) | $709.10 K(-18.1%) |
| Sept 2004 | - | $91.60 K(-70.9%) | $865.90 K(+11.8%) |
| June 2004 | - | $314.60 K(+33.0%) | $774.30 K(+68.4%) |
| Mar 2004 | $459.80 K(+328.5%) | $236.50 K(+6.0%) | $459.70 K(+39.1%) |
| Dec 2003 | - | $223.20 K(>+9900.0%) | $330.50 K(+208.0%) |
| Sept 2003 | - | $0.00(0.0%) | $107.30 K(0.0%) |
| June 2003 | - | $0.00(-100.0%) | $107.30 K(0.0%) |
| Mar 2003 | $107.30 K(>+9900.0%) | $107.30 K(>+9900.0%) | $107.30 K(>+9900.0%) |
| Dec 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2001 | - | $0.00(0.0%) | -$8100.00(-94.4%) |
| Sept 2001 | - | $0.00(0.0%) | -$144.40 K(-19.3%) |
| June 2001 | - | $0.00(-100.0%) | -$179.00 K(-212.9%) |
| Mar 2001 | $158.60 K(>+9900.0%) | -$8100.00(-94.1%) | $158.60 K(-4.9%) |
| Dec 2000 | - | -$136.30 K(+293.9%) | $166.70 K(-45.0%) |
| Sept 2000 | - | -$34.60 K(-110.2%) | $303.00 K(-10.2%) |
| June 2000 | - | $337.60 K(>+9900.0%) | $337.60 K(>+9900.0%) |
| Mar 2000 | $0.00(0.0%) | - | - |
| Mar 1999 | $0.00(0.0%) | - | - |
| Mar 1998 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1997 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1997 | - | $0.00 | $0.00 |
| Mar 1997 | $434.80 K | - | - |
FAQ
- What is VBI Vaccines annual cash flow from financing activities?
- What is the all time high annual CFF for VBI Vaccines?
- What is VBI Vaccines annual CFF year-on-year change?
- What is VBI Vaccines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for VBI Vaccines?
- What is VBI Vaccines quarterly CFF year-on-year change?
- What is VBI Vaccines TTM cash flow from financing activities?
- What is the all time high TTM CFF for VBI Vaccines?
- What is VBI Vaccines TTM CFF year-on-year change?
What is VBI Vaccines annual cash flow from financing activities?
The current annual CFF of VBIV is $22.70 M
What is the all time high annual CFF for VBI Vaccines?
VBI Vaccines all-time high annual cash flow from financing activities is $122.39 M
What is VBI Vaccines annual CFF year-on-year change?
Over the past year, VBIV annual cash flow from financing activities has changed by +$3.25 M (+16.71%)
What is VBI Vaccines quarterly cash flow from financing activities?
The current quarterly CFF of VBIV is $843.00 K
What is the all time high quarterly CFF for VBI Vaccines?
VBI Vaccines all-time high quarterly cash flow from financing activities is $67.22 M
What is VBI Vaccines quarterly CFF year-on-year change?
Over the past year, VBIV quarterly cash flow from financing activities has changed by -$21.58 M (-96.24%)
What is VBI Vaccines TTM cash flow from financing activities?
The current TTM CFF of VBIV is $23.54 M
What is the all time high TTM CFF for VBI Vaccines?
VBI Vaccines all-time high TTM cash flow from financing activities is $144.62 M
What is VBI Vaccines TTM CFF year-on-year change?
Over the past year, VBIV TTM cash flow from financing activities has changed by +$1.11 M (+4.97%)